Teva Pharmaceutical Industries Aktie
15,70 EUR -0,55 EUR -3,38 %
BMN
18,37 USD ±0,00 USD ±0,00 %
nachbörslichBTT
BTT
Teva Pharmaceutical Industries jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Werbung
Teva Pharmaceutical Industries Rating
Teva Pharmaceutical Industries Ltd. (spons. ADRs) Aktie Moody's Rating
Ba1
C
A3
Aaa
Investmentwürdig - Hohe Sicherheit
Investmentwürdig - Mittlere Sicherheit
Nicht als Investment geeignet
Investmentwürdig - Mittlere Sicherheit
Nicht als Investment geeignet
| Rating | Ba1 | Rating Typ Bank Financial Strength Rating Insurance Financial Strength Rating Enhanced Rating Insured Rating Long-Term Bank Deposit Rating Long-Term OSO Rating Long-Term Debt Rating Money Market Fund Rating Modeled Shadow Rating Management Quality Rating Probability of Default Rating Pfd/Pref Stock Rating Prospective Pfd/Pref Rating Short-Term Bank Deposit Rating Speculative Grade Liquidity Rating Prospective LT Debt Rating Short-Term Insurance Financial Strength Rating Short-Term OSO Rating Servicer Quality Short-Term Debt Rating Lloyd´s Syndicate Performance Rating Underlying Rating Unknown - for conversion use only | Long-Term Debt Rating |
| Letzte Aktion | Upgrade | Moody's Büro in | - |
Anleihen von Teva Pharmaceutical Industries Ltd. (spons. ADRs) mit Moody's Ratings
| Emittent | Anzahl Anleihen | Ratings |
|---|---|---|
| Teva Pharmaceutical Finance Co. LLC | 2 | Ba1 |
Werbung
Werbung
Moody's Ratings Peer Group
| Aktie | Rating |
|---|---|
| AstraZeneca PLC | A1 |
| Merck Co. | Aa3 |
| Pfizer Inc. | A1 |
| Pfizer Inc. | A2 |
| Sanofi S.A. | Aa3 |
Beste Ratings aus der gleichen Branche
Passende Anleihen
| WKN | Emittent | Kupon | Fälligkeit |
|---|---|---|---|
| A0GMZX | Teva Pharmaceutical Finance LLC | 6,150% | 01.02.2036 |